Vaccine (Include COVID-19) - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2757517
- Published On: Oct, 2024
- Category : Healthcare & Pharma
- Pages : 161
-
According to Ample Market Research, the global market for Vaccine (Include COVID-19) should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Vaccine (Include COVID-19) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Vaccine (Include COVID-19) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Public grew percent to account for percent of the total market sales, and Private grew percent.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
This report studies and analyses global Vaccine (Include COVID-19) status and future trends, to help determine the Vaccine (Include COVID-19) market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Vaccine (Include COVID-19), and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Vaccine (Include COVID-19) market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Vaccine (Include COVID-19) by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Vaccine (Include COVID-19) by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Vaccine (Include COVID-19) key consuming regions, consumption value and demand structure
(5) Vaccine (Include COVID-19) industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
KM Biologics
Pfizer
Merck
Sinovac
Zhejiang Pukang
Walvax Biotechnology
Bharat Biotech
Serum Institute
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
LG Life Sciences
Market segment by Type, covers
Inactivated Vaccine
Attenuated Vaccine
mRNA
Other
Market segment by Application, can be divided into
Public
Private
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Vaccine (Include COVID-19) product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Vaccine (Include COVID-19) market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Vaccine (Include COVID-19) market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Vaccine (Include COVID-19) industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Vaccine (Include COVID 19) Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Vaccine (Include COVID-19) Definition
1.2 Global Vaccine (Include COVID-19) Market Size and Forecast
1.3 China Vaccine (Include COVID-19) Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Vaccine (Include COVID-19) Market Size: China VS Global Growth Rate, 2018-2029
1.6 Vaccine (Include COVID-19) Market Dynamics
1.6.1 Vaccine (Include COVID-19) Market Drivers
1.6.2 Vaccine (Include COVID-19) Market Restraints
1.6.3 Vaccine (Include COVID-19) Industry Trends
1.6.4 Vaccine (Include COVID-19) Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Vaccine (Include COVID-19), Global Market Share by Company, 2018-2023
2.2 Global Vaccine (Include COVID-19) Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Vaccine (Include COVID-19) Concentration Ratio
2.4 Global Vaccine (Include COVID-19) Mergers & Acquisitions, Expansion Plans
2.5 Global Vaccine (Include COVID-19) Major Companies Product Type
2.6 Head Office and Vaccine (Include COVID-19) Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Vaccine (Include COVID-19), China Market Share by Company, 2018-2023
3.2 China Vaccine (Include COVID-19) Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Vaccine (Include COVID-19) Industry Chain
4.2 Vaccine (Include COVID-19) Upstream Analysis
4.2.1 Vaccine (Include COVID-19) Core Raw Materials
4.2.2 Main Manufacturers of Vaccine (Include COVID-19) Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Vaccine (Include COVID-19) Production Mode
4.6 Vaccine (Include COVID-19) Procurement Model
4.7 Vaccine (Include COVID-19) Industry Sales Model and Sales Channels
4.7.1 Vaccine (Include COVID-19) Sales Model
4.7.2 Vaccine (Include COVID-19) Typical Distributors
5 Sights by Type5.1 Vaccine (Include COVID-19) Classification
5.1.1 Inactivated Vaccine
5.1.2 Attenuated Vaccine
5.1.3 mRNA
5.1.4 Other5.2 By Type, Global Vaccine (Include COVID-19) Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Vaccine (Include COVID-19) Consumption Value, 2018-2029
6 Sights by Application6.1 Vaccine (Include COVID-19) Segment by Application
6.1.1 Public
6.1.2 Private6.2 By Application, Global Vaccine (Include COVID-19) Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Vaccine (Include COVID-19) Consumption Value, 2018-2029
7 Sales Sights by Region7.1 By Region, Global Vaccine (Include COVID-19) Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Vaccine (Include COVID-19) Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Vaccine (Include COVID-19) & Forecasts, 2018-2029
7.3.2 By Country, North America Vaccine (Include COVID-19) Market Size Market Share7.4 Europe
7.4.1 Europe Vaccine (Include COVID-19) Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Vaccine (Include COVID-19) Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Vaccine (Include COVID-19) Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Vaccine (Include COVID-19) Market Size Market Share7.6 South America
7.6.1 South America Vaccine (Include COVID-19) Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Vaccine (Include COVID-19) Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Vaccine (Include COVID-19) Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Vaccine (Include COVID-19) Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Vaccine (Include COVID-19) Market Size, 2018-2029
8.3.2 By Type, U.S. Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 20298.4 Europe
8.4.1 Europe Vaccine (Include COVID-19) Market Size, 2018-2029
8.4.2 By Type, Europe Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 20298.5 China
8.5.1 China Vaccine (Include COVID-19) Market Size, 2018-2029
8.5.2 By Type, China Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 20298.6 Japan
8.6.1 Japan Vaccine (Include COVID-19) Market Size, 2018-2029
8.6.2 By Type, Japan Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Vaccine (Include COVID-19) Market Size, 2018-2029
8.7.2 By Type, South Korea Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Vaccine (Include COVID-19) Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Vaccine (Include COVID-19) Market Size, 2018-2029
8.9.2 By Type, India Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 20298.10 Middle East & Africa
8.10.1 Middle East & Africa Vaccine (Include COVID-19) Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Vaccine (Include COVID-19) Consumption Value Market Share, 2022 VS 2029
9 Company Profile9.1 Sanofi
9.1.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.1.2 Sanofi Company Profile and Main Business
9.1.3 Sanofi Vaccine (Include COVID-19) Models, Specifications and Application
9.1.4 Sanofi Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.1.5 Sanofi Recent Developments9.2 CSL
9.2.1 CSL Company Information, Head Office, Market Area and Industry Position
9.2.2 CSL Company Profile and Main Business
9.2.3 CSL Vaccine (Include COVID-19) Models, Specifications and Application
9.2.4 CSL Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.2.5 CSL Recent Developments9.3 GSK
9.3.1 GSK Company Information, Head Office, Market Area and Industry Position
9.3.2 GSK Company Profile and Main Business
9.3.3 GSK Vaccine (Include COVID-19) Models, Specifications and Application
9.3.4 GSK Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.3.5 GSK Recent Developments9.4 Viatris
9.4.1 Viatris Company Information, Head Office, Market Area and Industry Position
9.4.2 Viatris Company Profile and Main Business
9.4.3 Viatris Vaccine (Include COVID-19) Models, Specifications and Application
9.4.4 Viatris Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.4.5 Viatris Recent Developments9.5 AstraZeneca
9.5.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
9.5.2 AstraZeneca Company Profile and Main Business
9.5.3 AstraZeneca Vaccine (Include COVID-19) Models, Specifications and Application
9.5.4 AstraZeneca Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.5.5 AstraZeneca Recent Developments9.6 Hualan Bio
9.6.1 Hualan Bio Company Information, Head Office, Market Area and Industry Position
9.6.2 Hualan Bio Company Profile and Main Business
9.6.3 Hualan Bio Vaccine (Include COVID-19) Models, Specifications and Application
9.6.4 Hualan Bio Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.6.5 Hualan Bio Recent Developments
9.7 Changchun Institute of Biological
9.7.1 Changchun Institute of Biological Company Information, Head Office, Market Area and Industry Position
9.7.2 Changchun Institute of Biological Company Profile and Main Business
9.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Models, Specifications and Application
9.7.4 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.7.5 Changchun Institute of Biological Recent Developments
9.8 Sinovac
9.8.1 Sinovac Company Information, Head Office, Market Area and Industry Position
9.8.2 Sinovac Company Profile and Main Business
9.8.3 Sinovac Vaccine (Include COVID-19) Models, Specifications and Application
9.8.4 Sinovac Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.8.5 Sinovac Recent Developments
9.9 KM Biologics
9.9.1 KM Biologics Company Information, Head Office, Market Area and Industry Position
9.9.2 KM Biologics Company Profile and Main Business
9.9.3 KM Biologics Vaccine (Include COVID-19) Models, Specifications and Application
9.9.4 KM Biologics Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.9.5 KM Biologics Recent Developments9.10 Pfizer
9.10.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.10.2 Pfizer Company Profile and Main Business
9.10.3 Pfizer Vaccine (Include COVID-19) Models, Specifications and Application
9.10.4 Pfizer Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.10.5 Pfizer Recent Developments
9.11 Merck
9.11.1 Merck Company Information, Head Office, Market Area and Industry Position
9.11.2 Merck Company Profile and Main Business
9.11.3 Merck Vaccine (Include COVID-19) Models, Specifications and Application
9.11.4 Merck Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.11.5 Merck Recent Developments
9.12 Sinovac
9.12.1 Sinovac Company Information, Head Office, Market Area and Industry Position
9.12.2 Sinovac Company Profile and Main Business
9.12.3 Sinovac Vaccine (Include COVID-19) Models, Specifications and Application
9.12.4 Sinovac Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.12.5 Sinovac Recent Developments
9.13 Zhejiang Pukang
9.13.1 Zhejiang Pukang Company Information, Head Office, Market Area and Industry Position
9.13.2 Zhejiang Pukang Company Profile and Main Business
9.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Models, Specifications and Application
9.13.4 Zhejiang Pukang Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.13.5 Zhejiang Pukang Recent Developments
9.14 Walvax Biotechnology
9.14.1 Walvax Biotechnology Company Information, Head Office, Market Area and Industry Position
9.14.2 Walvax Biotechnology Company Profile and Main Business
9.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Models, Specifications and Application
9.14.4 Walvax Biotechnology Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.14.5 Walvax Biotechnology Recent Developments
9.15 Bharat Biotech
9.15.1 Bharat Biotech Company Information, Head Office, Market Area and Industry Position
9.15.2 Bharat Biotech Company Profile and Main Business
9.15.3 Bharat Biotech Vaccine (Include COVID-19) Models, Specifications and Application
9.15.4 Bharat Biotech Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.15.5 Bharat Biotech Recent Developments
9.16 Serum Institute
9.16.1 Serum Institute Company Information, Head Office, Market Area and Industry Position
9.16.2 Serum Institute Company Profile and Main Business
9.16.3 Serum Institute Vaccine (Include COVID-19) Models, Specifications and Application
9.16.4 Serum Institute Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.16.5 Serum Institute Recent Developments
9.17 Panacea Biotec Ltd
9.17.1 Panacea Biotec Ltd Company Information, Head Office, Market Area and Industry Position
9.17.2 Panacea Biotec Ltd Company Profile and Main Business
9.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Models, Specifications and Application
9.17.4 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.17.5 Panacea Biotec Ltd Recent Developments
9.18 Bio-Med
9.18.1 Bio-Med Company Information, Head Office, Market Area and Industry Position
9.18.2 Bio-Med Company Profile and Main Business
9.18.3 Bio-Med Vaccine (Include COVID-19) Models, Specifications and Application
9.18.4 Bio-Med Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.18.5 Bio-Med Recent Developments
9.19 Halfkin Bio-Pharmaceuticals
9.19.1 Halfkin Bio-Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.19.2 Halfkin Bio-Pharmaceuticals Company Profile and Main Business
9.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Models, Specifications and Application
9.19.4 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.19.5 Halfkin Bio-Pharmaceuticals Recent Developments9.20 LG Life Sciences
9.20.1 LG Life Sciences Company Information, Head Office, Market Area and Industry Position
9.20.2 LG Life Sciences Company Profile and Main Business
9.20.3 LG Life Sciences Vaccine (Include COVID-19) Models, Specifications and Application
9.20.4 LG Life Sciences Vaccine (Include COVID-19) Revenue and Gross Margin, 2018-2023
9.20.5 LG Life Sciences Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Vaccine (Include COVID 19) Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Vaccine (Include COVID 19) Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Vaccine (Include COVID 19) Global and China Top Players has a wide range of applications, including
The Vaccine (Include COVID 19) Global and China Top Players Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
The influx of capital into the Vaccine (Include COVID 19) Global and China Top Players Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
The Vaccine (Include COVID 19) Global and China Top Players Market is expected to reach a considerable market valuation.
